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Abstract: 
Pharmacophore feature is defined by a set of chemical structure patterns having the active site of drug like molecule. Pharmacophore can be used to assist in 
building hypothesis about desirable chemical properties in drug molecule and hence it can be used to refine and modify drug candidates. We predicted the 
pharmacophoric features of 150 medicinal compounds from plants for anti-cancer, anti-carcinogenic, anti-diabetic, anti-microbial, and anti-oxidant. Estimation of 
pharmacophoric feature is necessary to ensure the optimal supramolecular interaction with a biological target and to trigger or block its biological response. We 
subsequently make this data available to open access using a database at the URL: http://www.hccbif.info/index.htm 
 
 
Availability: http://www.hccbif.info/index.htm 
 
 
Keywords: Anti Diabetic, Anti Cancer, Anti Microbial, Pharmacophoric features, Phase. 
 
 
 
 
Background: 
The traditional Indian medicine and use of phytocompounds against various 
diseases receive considerable attention in recent years. Plant-derived drugs 
remain an important resource, especially in developing countries to combat 
serious diseases. Approximately 60-80% of the world’s population still relies 
on traditional medicines for the treatment of common illness [1-2]. 
Pharmacophore screening is one of the useful ways to uncover a set of features 
that is common to a series of active molecules responsible for the activity [3]. 
Perceiving a pharmacophore is the most important first step towards 
understanding the interaction between a receptor and a ligand. Paul Ehrlich 
(1900) defined a pharmacophore as "a molecular framework that carries 
(phoros) the essential features responsible for a drug's (pharmacon) biological 
activity" [4]. That definition of pharmacophore remained unperturbed for over 
90 years. The current widely used definition was presented by Peter Gund 
(1977) refined a pharmacophore as "a set of structural features in a molecule 
that is recognized at a receptor site and is responsible for that molecule's 
biological activity" [5].This definition is remarkably loyal to the earlier 
definition. A pharmacophore is an exact description of molecular features 
which are necessary for  molecular recognition of a ligand required biological  
macromolecule. The IUPAC defines a pharmacophore to be "an ensemble of 
steric and electronic features that is necessary to ensure the optimal 
supramolecular interactions with a specific biological target and to trigger (or 
block) its biological response [6]. Typical pharmacophore of a molecule consist 
of features like, hydrophobic, aromatic, a hydrogen bond acceptor, a hydrogen 
bond donor, negative and positive functional groups. Here, an effort has been 
taken to find the Pharmacophoric sites of certain medicinal compounds by 
using PHASE module. The application of database is to help researchers; 
particularly working with medicinal compounds. Through this database, they 
may get idea about ligand chemical features. Molecular level studies of 
pharmacophore explain about active site of drug molecule, which is important 
for interaction with binding target. Theoretical prediction of Pharmacophoric 
features of these compounds includes hydrogen bond donor, hydrogen bond 
acceptor, hydrophobic, aromatic, positive and negative features. These 
characteristics of ligand molecules are considered as pharmacophoric sites 
based on the differentiation (Figure 1). These pharmacophore are considered to 
be an essential part of a compound to become a drug, thereby these. 
pharmacophoric features can be an advantage for researchers to know about the 
chemical features and functional properties of ligand molecule. 
 
Methodology: 
Data collection & Preparation: 
The dataset consists of 150 medicinal compounds collected from 
http://www.hccbif.info/ of which 89 are anti cancerous & anticarcinogenic, 43 
are antidiabetic, 47 are antimicrobial and 5 are anti oxidants [7]. Data set are 
prepared by ligprep cleaned structures for molecular modeling environment. 
Prepared ligands are processed for pharmacophoric features through 
Pharmacophore Alignment and Scoring Engine (PHASE) module of 
Schrodinger suite, which is a recently developed pharmacophore modeling 
package, for all the above mentioned series of compounds. 
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Figure 1: Database workflow for pharmacophoric prediction of medicinal 
compounds 
 
Creating Pharmacophoric Sites: 
Phase locates features using SMARTS pattern matching, making it easy to 
modify existing feature definitions and to create entirely new custom features. 
Intuitive visualization tools and the rapid location of sites help researchers fine-
tune feature definitions. Each compound structure is represented by a set of 
points in 3D space, which coincide with various chemical features that may 
facilitate non-covalent binding between the compound and its target receptor. 
PHASE provides a built-in set of six pharmacophore features, hydrogen bond 
acceptor(A), hydrogen bond donor(D), hydrophobic group(H), negatively 
ionizable (N), positively ionizable (P), and aromatic ring(R). By this 
methodology the pharmacophoric features are predicted and deposited in 
database [8-10]. 
 
Utility for biological community: 
A Pharmacophore is defined as an ensemble of universal chemical features that 
characterize a specific mode of action of a ligand in active site of the 
macromolecule in 3D space. Due to its importance, this method is 
computationally very efficient and is subsequently well suited for virtual 
screening of large compound libraries. This Database is open source and freely 
available. Applications of the work consists of user interface with dynamic web 
pages, more than 150 medicinal compounds having anti-carcinogenic, anti-
cancerous, anti-diabetic, anti-microbial and anti-oxidant activity, Theoretical 
prediction of chemical features using commercial software’s are applicable for 
the researchers working on medical plants. Pharmacophore predicted in this 
work would consider to be very useful for further development of ligand based 
new analog for finding a new active compound with similar Pharmacophoric 
features and the knowledge of the pharamacophore will result in the generation 
of several leads. Pharmacophore of these compounds can explain very well 
about the physiochemical properties required for the designing of new 
compounds of these series. 
 
Future development: 
We plan to refine and keep updating this database and to provide more 
medicinal compounds with bio-physiochemical properties. 
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